Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma.

Scandinavian journal of rheumatology - 1 Jan 2011

Danielides S, Mavragani C P, Katsakoulas I, Zintzaras E, Drosos A A, Vlachoyiannopoulos P G, Moutsopoulos H M

Abstract excerpt

OBJECTIVES: Thyroid dysfunction in the setting of systemic sclerosis (SSc) has been described previously. We aimed to determine the prevalence of anti-thyroid antibodies (ATA) in a large SSc cohort and to ascertain whether they are associated with distinct clinical phenotypes. METHODS: A total of 138 patients with SSc [46 with diffuse (dSSc) and 92 with limited scleroderma (lSSc)] and 100 healthy controls (HC)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antibodies, Anti-Idiotypic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Autoantibodies

Share to Case-Control Studies

Share to Cohort Studies

Share to Iodide Peroxidase

Share to Phenotype

Share to Thyroid Gland

Source

Identifiers

PMID: 21417550
DOI: 10.3109/03009742.2010.549837

Genes

TPO

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma.PMID 21417550Read ↗

Disease-related autoantibody profile in patients with systemic sclerosisSemantic proximity Read ↗

Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement.Semantic proximity Read ↗

Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes.Semantic proximity Read ↗

Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosisSemantic proximity Read ↗

Autoantibodies targeting telomere-associated proteins in systemic sclerosisSemantic proximity Read ↗

Anti‐centromere antibodies in patients with systemic lupus erythematosusSemantic proximity Read ↗

HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies.Semantic proximity Read ↗

Autoantibody to th ribonucleoprotein (nucleolar 7–2 rna protein particle) in patients with systemic sclerosisSemantic proximity Read ↗

Systemic sclerosis and prevalence of monoclonal immunoglobulin.Semantic proximity Read ↗

Presence of nucleosome‐restricted antibodies in patients with systemic lupus erythematosusSemantic proximity Read ↗

Oligoclonal T Cell Expansion in the Skin of Patients with Systemic SclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.